25/100B40.640
USD
-0.02
(-0.05%)
Market Open
Last updated: · Delayed 15 min
Roivant Sciences current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Roivant Sciences's current ratio is 15.03: current assets of 4.21B USD against current liabilities of 279.91M USD due within a year.
- Today
- 15.03
- Average, 5 years
- 21.46
- Low, 5 years
- 5.84
- High, 5 years
- 40.54
Current ratio = current assets ÷ current liabilities = 4.21B ÷ 279.91M = 15.03
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 15.03 | 4.21B | 279.91M | |
| FY2025 | 31 Mar 2026 | 18.37 | 5.17B | 281.24M |
| FY2024 | 31 Mar 2025 | 33.47 | 5.00B | 149.41M |
| FY2023 | 31 Mar 2024 | 25.24 | 6.73B | 266.76M |
| FY2022 | 31 Mar 2023 | 6.60 | 1.80B | 272.45M |
| FY2021 | 31 Mar 2022 | 11.64 | 2.15B | 184.37M |
| FY2020 | 31 Mar 2021 | 9.99 | 2.19B | 218.96M |
| FY2019 | 31 Mar 2020 | 24.09 | 2.22B | 92.12M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q2 FY2026 | 30 Sept 2026 | 15.03 | 4.21B | 279.91M |
| Q1 FY2026 | 30 Jun 2026 | 16.72 | 4.74B | 283.60M |
| Q4 FY2025 | 31 Mar 2026 | 18.37 | 5.17B | 281.24M |
| Q3 FY2025 | 31 Dec 2025 | 30.66 | 4.66B | 151.96M |
| Q2 FY2025 | 30 Sept 2025 | 33.70 | 4.51B | 133.86M |
| Q1 FY2025 | 30 Jun 2025 | 40.54 | 4.62B | 113.87M |
| Q4 FY2024 | 31 Mar 2025 | 33.47 | 5.00B | 149.41M |
| Q3 FY2024 | 31 Dec 2024 | 37.91 | 5.36B | 141.48M |
| Q2 FY2024 | 17 Sept 2024 | 10.43 | 5.80B | 556.25M |
| Q1 FY2024 | 30 Jun 2024 | 27.91 | 6.00B | 215.05M |
| Q4 FY2023 | 31 Mar 2024 | 25.24 | 6.73B | 266.76M |
| Q3 FY2023 | 31 Dec 2023 | 27.79 | 6.81B | 244.90M |
| Q2 FY2023 | 30 Sept 2023 | 5.84 | 1.55B | 265.55M |
| Q1 FY2023 | 30 Jun 2023 | 6.37 | 1.56B | 245.00M |
| Q4 FY2022 | 31 Mar 2023 | 6.60 | 1.80B | 272.45M |
| Q3 FY2022 | 31 Dec 2022 | 6.74 | 1.65B | 244.26M |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about Roivant Sciences's current ratio
Source: Financial Modeling Prep